ReviewCells2020

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.

Loris ZamaiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.